AFLURIA QUADRIVALENT 0.25ML (2019/2020) CPT Vaccine Code: 90687

Vaccine & Product Overview

HCPCS Descriptor Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.25 mL dosage, for intramuscular use

Manufacturer Seqirus

Route of Administration Intramuscular, Oral

Generic Status Multi-Source; Generic

About AFLURIA QUADRIVALENT 0.25ML (2019/2020)

Afluria Quadrivalent 0.25ml (2019/2020) is a medication aligned to the HCPCS CPT Drug Code: 90687 for billing, pricing, and reimbursement purposes in the United States. It is a Vaccine drug administered via the intramuscular or oral routes and manufactured by Seqirus.

Manufacturers, reach out to us to add more information.

NDC Code Information

2 NDC packages are crosswalked to 90687. Package detail is available to logged-in subscribers.

NDC Code	Drug	Manufacturer	Billing Units / Pkg	Package Size
•••••-••••-•• Log in to view	AFLURIA QUADRIVALENT 0.25ML (2019/2020)
	AFLURIA QUADRIVALENT 0.25ML (2019/2020)

Login to view 2 NDC packages View pricing, complete NDC-to-HCPCS alignments, and package details.

Login →

AFLURIA QUADRIVALENT 0.25ML (2019/2020) Vaccine Administration Codes

Medicare bills the administration of AFLURIA QUADRIVALENT 0.25ML (2019/2020) with HCPCS code G0008, and allows simplified roster billing when vaccinating multiple patients. The CPT codes below apply to non-Medicare payers.

Code	Description
G0008	Administration of influenza virus vaccine (Medicare)
90460	Immunization administration via any route, first vaccine/toxoid component
90461	Immunization administration through 18 years of age via any route of administration, with counseling by physician or other qualified health care professional; each additional vaccine or toxoid component (List separately in addition to code for primary procedure).
90471 Login for More	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), one vaccine (single or combination vaccine/toxoid) Login for More

AFLURIA QUADRIVALENT 0.25ML (2019/2020) Medically Unlikely Edits (MUE)

The most billing units of 90687 Medicare will pay for one patient in one day, as published by CMS. 1 unit = 0.25 ml.

Practitioner Office & Hospital Outpatient

1 unit / day

= 0.25 ml per day

MAI 2 · Date of Service Edit: Policy. Absolute per-day limit set by policy or regulation; units above it are not payable, and denials are not appealable on medical-necessity grounds. See all MUE limits →

AFLURIA QUADRIVALENT 0.25ML (2019/2020) Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

Prevention of influenza disease caused by influenza A subtype viruses and type B viruses contained in the vaccine.

Frequently Asked Questions

Is there an available Afluria Quadrivalent 0.25Ml (2019/2020) billing and coding guide?

Billing and coding information for AFLURIA QUADRIVALENT 0.25ML (2019/2020) can be found through Seqirus. Visit Here →

Are there any available Afluria Quadrivalent 0.25Ml (2019/2020) patient assistance programs?

Our team has not identified a manufacturer-published source of patient assistance information for AFLURIA QUADRIVALENT 0.25ML (2019/2020).

Where can I find Afluria Quadrivalent 0.25Ml (2019/2020) prescribing information?

AFLURIA QUADRIVALENT 0.25ML (2019/2020) prescribing information can be found at the link below: Visit Here →

Where can I find Afluria Quadrivalent 0.25Ml (2019/2020) side effect information?

Our team has not yet identified a source of side effects information for AFLURIA QUADRIVALENT 0.25ML (2019/2020). Please check back in a few weeks.

Does billing AFLURIA QUADRIVALENT 0.25ML (2019/2020) require JZ/JW wastage modifiers?

CMS does not include AFLURIA QUADRIVALENT 0.25ML (2019/2020) (90687) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing 90687. For more information, visit the link below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.